Application of linked DNA markers to screening families with multiple endocrine neoplasia type 2A. 1990

H Telenius, and C G Mathew, and Y Nakamura, and D F Easton, and J Clark, and H P Neumann, and W H Ziegler, and A Schinzel, and B A Ponder
Institute of Cancer Research, Haddow Laboratories, Sutton, Surrey, UK.

There now exists a set of tightly linked markers to the gene causing multiple endocrine neoplasia type 2A. In this report we discuss the use of these markers for early and accurate prediction of gene carrier status in three different families. Factors that influence the probability of obtaining useful information with DNA markers are available family size, in particular the number of available affected individuals, and the extent of clinical and biochemical screening in the family. At present, DNA analysis has about a 3% risk of misdiagnosis; this risk is even lower if it is used in conjunction with the pentagastrin stimulation test for C-cell hyperplasia. With the combined tests, an individual at age 20 years may be scored as carrier or not with an estimated accuracy of 99%.

UI MeSH Term Description Entries
D008040 Genetic Linkage The co-inheritance of two or more non-allelic GENES due to their being located more or less closely on the same CHROMOSOME. Genetic Linkage Analysis,Linkage, Genetic,Analyses, Genetic Linkage,Analysis, Genetic Linkage,Genetic Linkage Analyses,Linkage Analyses, Genetic,Linkage Analysis, Genetic
D008297 Male Males
D009377 Multiple Endocrine Neoplasia A group of autosomal dominant diseases characterized by the combined occurrence of tumors involving two or more ENDOCRINE GLANDS that secrete PEPTIDE HORMONES or AMINES. These neoplasias are often benign but can be malignant. They are classified by the endocrine glands involved and the degree of aggressiveness. The two major forms are MEN1 and MEN2 with gene mutations on CHROMOSOME 11 and CHROMOSOME 10, respectively. Adenomatosis, Familial Endocrine,Endocrine Neoplasia, Multiple,Multiple Endocrine Neoplasia Syndrome,Neoplasia, Multiple Endocrine,Neoplasms, Multiple Endocrine,Adenomatosis, Multiple Endocrine,Familial Endocrine Adenomatosis,Multiple Endocrine Adenomatosis,Multiple Endocrine Adenopathy,Multiple Endocrine Neoplasia Syndromes,Multiple Endocrine Neoplasms,Adenomatoses, Familial Endocrine,Adenomatoses, Multiple Endocrine,Adenopathies, Multiple Endocrine,Adenopathy, Multiple Endocrine,Endocrine Adenomatoses, Familial,Endocrine Adenomatoses, Multiple,Endocrine Adenomatosis, Familial,Endocrine Adenomatosis, Multiple,Endocrine Adenopathies, Multiple,Endocrine Adenopathy, Multiple,Endocrine Neoplasms, Multiple,Familial Endocrine Adenomatoses,Multiple Endocrine Adenomatoses,Multiple Endocrine Adenopathies
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D005260 Female Females
D005819 Genetic Markers A phenotypically recognizable genetic trait which can be used to identify a genetic locus, a linkage group, or a recombination event. Chromosome Markers,DNA Markers,Markers, DNA,Markers, Genetic,Genetic Marker,Marker, Genetic,Chromosome Marker,DNA Marker,Marker, Chromosome,Marker, DNA,Markers, Chromosome
D005820 Genetic Testing Detection of a MUTATION; GENOTYPE; KARYOTYPE; or specific ALLELES associated with genetic traits, heritable diseases, or predisposition to a disease, or that may lead to the disease in descendants. It includes prenatal genetic testing. Genetic Predisposition Testing,Genetic Screening,Predictive Genetic Testing,Predictive Testing, Genetic,Testing, Genetic Predisposition,Genetic Predictive Testing,Genetic Screenings,Genetic Testing, Predictive,Predisposition Testing, Genetic,Screening, Genetic,Screenings, Genetic,Testing, Genetic,Testing, Genetic Predictive,Testing, Predictive Genetic
D006580 Genetic Carrier Screening Identification of individuals who are heterozygous at a GENETIC LOCUS for a recessive PHENOTYPE. Carriers, Genetic, Detection,Genetic Carriers, Detection,Heterozygote Detection,Carrier Detection, Genetic,Detection, Genetic Carrier,Genetic Carrier Detection,Heterozygote Screening,Carrier Screening, Genetic,Detection, Heterozygote,Screening, Genetic Carrier,Screening, Heterozygote,Screenings, Genetic Carrier
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

H Telenius, and C G Mathew, and Y Nakamura, and D F Easton, and J Clark, and H P Neumann, and W H Ziegler, and A Schinzel, and B A Ponder
January 1988, Lancet (London, England),
H Telenius, and C G Mathew, and Y Nakamura, and D F Easton, and J Clark, and H P Neumann, and W H Ziegler, and A Schinzel, and B A Ponder
January 1991, Lancet (London, England),
H Telenius, and C G Mathew, and Y Nakamura, and D F Easton, and J Clark, and H P Neumann, and W H Ziegler, and A Schinzel, and B A Ponder
September 1994, The New England journal of medicine,
H Telenius, and C G Mathew, and Y Nakamura, and D F Easton, and J Clark, and H P Neumann, and W H Ziegler, and A Schinzel, and B A Ponder
October 1989, The New England journal of medicine,
H Telenius, and C G Mathew, and Y Nakamura, and D F Easton, and J Clark, and H P Neumann, and W H Ziegler, and A Schinzel, and B A Ponder
January 1992, Henry Ford Hospital medical journal,
H Telenius, and C G Mathew, and Y Nakamura, and D F Easton, and J Clark, and H P Neumann, and W H Ziegler, and A Schinzel, and B A Ponder
April 2003, Clinical endocrinology,
H Telenius, and C G Mathew, and Y Nakamura, and D F Easton, and J Clark, and H P Neumann, and W H Ziegler, and A Schinzel, and B A Ponder
January 2013, Chinese medical journal,
H Telenius, and C G Mathew, and Y Nakamura, and D F Easton, and J Clark, and H P Neumann, and W H Ziegler, and A Schinzel, and B A Ponder
January 1992, Henry Ford Hospital medical journal,
H Telenius, and C G Mathew, and Y Nakamura, and D F Easton, and J Clark, and H P Neumann, and W H Ziegler, and A Schinzel, and B A Ponder
June 2012, The Kaohsiung journal of medical sciences,
H Telenius, and C G Mathew, and Y Nakamura, and D F Easton, and J Clark, and H P Neumann, and W H Ziegler, and A Schinzel, and B A Ponder
June 1992, Internal medicine (Tokyo, Japan),
Copied contents to your clipboard!